A 52-year-old man on long-term warfarin for atrial fibrillation presents with sudden onset of severe pain in both legs and a petechial rash. INR is 1.8 (subtherapeutic). Imaging shows venous thrombosis with skin necrosis. Which investigation would best confirm the suspected diagnosis of protein C deficiency (warfarin-induced)?

Explanation

## Clinical Context: Warfarin-Induced Protein C Deficiency The patient presents with a rare but serious complication of warfarin initiation: **warfarin-induced skin necrosis and thrombosis**. This occurs when warfarin is started without adequate heparin bridging, causing a transient hypercoagulable state due to rapid depletion of **protein C** (which has a short half-life of ~8 hours). ## Pathophysiology **Key Point:** Warfarin inhibits vitamin K–dependent carboxylation of: - Clotting factors: II, VII, IX, X (anticoagulant effect) - **Protein C and protein S** (anticoagulant proteins) Protein C has the **shortest half-life** (~8 hours), so it is depleted first when warfarin is started. This creates a transient **hypercoagulable state** before the procoagulant factors are depleted, leading to thrombosis and skin necrosis. ## Why Plasma Protein C Activity is the Best Diagnostic Test **High-Yield:** Plasma protein C activity level is the **gold standard** for confirming warfarin-induced protein C deficiency because: 1. It directly measures the functional activity of protein C 2. It is specific for this diagnosis (other tests are non-specific) 3. Normal range: 70–140% of normal activity 4. In warfarin-induced protein C deficiency: markedly reduced (<20% activity) 5. It explains the paradoxical thrombosis despite anticoagulation **Clinical Pearl:** Warfarin-induced skin necrosis typically occurs on the **breasts, buttocks, abdomen, and lower extremities** — areas with high subcutaneous fat. The diagnosis is confirmed by demonstrating low protein C activity in the context of warfarin use and thrombosis. ## Differential Diagnosis of Coagulation Tests in This Scenario | Investigation | Finding in Warfarin-Induced Protein C Deficiency | Diagnostic Value | |---|---|---| | **Plasma protein C activity** | Markedly reduced (<20%) | ✓ **Gold standard** — directly confirms diagnosis | | PT/aPTT | PT prolonged (warfarin effect); aPTT may be normal or prolonged | Non-specific; reflects multiple vitamin K–dependent factors | | Serum vitamin K1 level | Normal or low | Does not explain the thrombosis; vitamin K deficiency alone does not cause thrombosis | | TT and fibrinogen | Normal (unless DIC develops) | Non-specific; not helpful for protein C deficiency | **Mnemonic:** **PACS** — **P**rotein C is **A**ffected **C**arly in warfarin **S**tart - Protein C depleted first (shortest half-life) - Creates transient hypercoagulable state - Causes thrombosis and skin necrosis - Confirmed by **plasma protein C activity** measurement ## Why Other Investigations Are Suboptimal - **PT/aPTT:** These are non-specific coagulation screening tests that reflect multiple vitamin K–dependent factors. They do not identify protein C deficiency specifically and do not explain the paradoxical thrombosis. - **Serum vitamin K1 level:** Vitamin K levels are not routinely measured and would not explain thrombosis. The problem is not vitamin K deficiency but rather selective depletion of the anticoagulant protein C. - **TT and fibrinogen:** These tests assess the final common pathway of coagulation and fibrinogen function. They are normal in warfarin-induced protein C deficiency and do not help diagnose this condition.